인쇄하기
취소
|
The Hanmi Pharm’s delayed report on the side effect of ‘Olita Tab’ was officially confirmed.
According to audit result on the Hanmi Pharm’s clinical trial for Olita Tab, requested by the National Assembly, the Board of Audit and Inspection(BAI) announced on the 17th that it was true that Hanmi Pharm violated the regulation by postponing the clinical result report by 14 months, but it was not f...